141 related articles for article (PubMed ID: 26243667)
1. Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca(2+) removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendan.
Wagner S; Schürmann S; Hein S; Schüttler J; Friedrich O
Basic Res Cardiol; 2015 Sep; 110(5):507. PubMed ID: 26243667
[TBL] [Abstract][Full Text] [Related]
2. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
3. The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.
Behrends M; Peters J
Intensive Care Med; 2003 Oct; 29(10):1802-7. PubMed ID: 12879240
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
6. In contrast to its anti-inflammatory and anti-apoptotic peripheral effect, levosimendan failed to induce a long-term neuroprotective effect in a rat model of mild septic encephalopathy: a pilot study.
Plaschke K; Bent F; Wagner S; Zorn M; Kopitz J
Neurosci Lett; 2014 Feb; 560():117-21. PubMed ID: 24361133
[TBL] [Abstract][Full Text] [Related]
7. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
8. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice.
Schellekens WJ; van Hees HW; Linkels M; Dekhuijzen PN; Scheffer GJ; van der Hoeven JG; Heunks LM
Crit Care; 2015 Mar; 19(1):69. PubMed ID: 25888356
[TBL] [Abstract][Full Text] [Related]
10. Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.
Wilson K; Guggilam A; West TA; Zhang X; Trask AJ; Cismowski MJ; de Tombe P; Sadayappan S; Lucchesi PA
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1605-17. PubMed ID: 25260618
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization.
Bowman P; Haikala H; Paul RJ
J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786
[TBL] [Abstract][Full Text] [Related]
12. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells.
Yokoshiki H; Katsube Y; Sunagawa M; Sperelakis N
J Pharmacol Exp Ther; 1997 Oct; 283(1):375-83. PubMed ID: 9336346
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan improves diastolic and systolic function in failing human myocardium.
Janssen PM; Datz N; Zeitz O; Hasenfuss G
Eur J Pharmacol; 2000 Sep; 404(1-2):191-9. PubMed ID: 10980279
[TBL] [Abstract][Full Text] [Related]
14. Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolated septic rat hearts.
Zausig YA; Geilfus D; Missler G; Sinner B; Graf BM; Zink W
Shock; 2010 Sep; 34(3):269-74. PubMed ID: 19997056
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium.
Brixius K; Reicke S; Schwinger RH
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H131-7. PubMed ID: 11748056
[TBL] [Abstract][Full Text] [Related]
16. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
17. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
[TBL] [Abstract][Full Text] [Related]
18. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan is superior to epinephrine in improving myocardial function after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats.
Rungatscher A; Linardi D; Tessari M; Menon T; Luciani GB; Mazzucco A; Faggian G
J Thorac Cardiovasc Surg; 2012 Jan; 143(1):209-14. PubMed ID: 22014715
[TBL] [Abstract][Full Text] [Related]
20. Role of levosimendan in sepsis and septic shock.
Pinto BB; Rehberg S; Ertmer C; Westphal M
Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
